Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion type Assertion NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_head.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion description "[A phase I/II trial was undertaken to define the feasibility, safety and antitumor effects of the autologous vaccine prepared by transferring tag7/PGRP-S gene into malignant melanoma and renal cell carcinoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_provenance.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion evidence source_evidence_literature NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_provenance.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion SIO_000772 15598955 NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_provenance.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion wasDerivedFrom befree-2016 NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_provenance.
- NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_assertion wasGeneratedBy ECO_0000203 NP472746.RA3rKh64Jgw45uVWLErxuZh5X1VtYS9pXm7B47FLR9yew130_provenance.